Ingredient · B-Vitamin · Optional Pairing

Niacin / Vitamin B3

Nicotinic acid

(vitamin B3, the flush form) and nicotinamide (the non-flush form). Compound class: water-soluble B-vitamin.

Optional protocol pairing — circulation and energy-metabolism cofactor.

Suggested Dose
25–50mg Flush Form
Used With
Active Botanical Formulas
Evidence
Tier 1 Nutrition · Tier 3–4 Pairing

An optional B-vitamin pairing within established Active Botanical cycling protocols — supports normal energy metabolism, never positioned as a required enhancer.

What It Is

A B-vitamin within established cycling traditions.

Niacin is vitamin B3 — an essential water-soluble vitamin available in two main supplement forms: nicotinic acid (the flush form, traditional in protocol context) and nicotinamide / niacinamide (the non-flush form). The two forms behave differently in the body. The flush form transiently activates skin vasodilation; the non-flush form does not.

Niacin is not present in any current MYKO capsule formulation. It appears on label directions for Active Botanical products as an optional 25–50mg flush-form pairing within Stamets-style protocols. This monograph treats niacin as protocol-support education, not as a current MYKO product.

Why MYKO Uses It

Optional pairing, not a required enhancer.

MYKO references niacin as optional protocol support inside Active Botanical product directions because it is a long-standing element of the Stamets cycling framework. The pairing is community-protocol-based and traditional within microdosing protocols, not a research-backed enhancement.

Effects & Experience

The flush is the experience — felt, not promised.

The flush is the experience: warm skin, redness, mild tingling, lasting 15–30 minutes. Many users find the flush unpleasant; some find it a useful body cue. The non-flush form has none of this character but contributes the same NAD+ support.

MYKO does not claim that niacin enhances Active Botanical effects. The pairing is offered for completeness within established community protocols, not as a required co-factor.

Key Bioactive Compounds

The chemistry MYKO selects for.

  • Nicotinic acid (flush form)
    Activates GPR109A receptors causing transient skin vasodilation (flushing). Converts to NAD+ in the body.
  • Nicotinamide / niacinamide (non-flush)
    Skips the GPR109A pathway and goes directly to NAD+ synthesis. No flushing.
  • NAD+ precursor activity
    Both forms support cellular NAD+ status — a central cofactor in cellular energy metabolism.
Mechanisms in the Body

Three pathways, three evidence levels.

Mechanism strength is presented separately so you can see what is human-supported, what is preclinical, and what is traditional theory.

Human-Supported
  • Niacin supports normal energy metabolism and the maintenance of normal skin and mucous membranes (recognized B3 nutritional roles).
  • Pharmacological doses (1–3g/day, prescription context) are used clinically for lipid management — not relevant to MYKO's 25–50mg pairing.
Preclinical / Mechanistic
  • GPR109A receptor activation by the flush form produces transient cutaneous vasodilation — the visible flush.
  • Both forms convert to NAD+ in the body, supporting cellular energy metabolism.
Traditional / Theoretical
  • Within microdosing community protocols, the Stamets stack has paired flush-form niacin with Active Botanical and Lion's Mane on dose days. The proposed rationale is peripheral circulation and possible distribution support — community theory, not established research.
Evidence Grade

How MYKO grades this ingredient.

Overall Grade
Tier 1 for established B3 nutritional roles. Tier 3–4 for the Active Botanical protocol-pairing rationale.
Strongest Areas
Niacin's role as a B3 vitamin essential for energy metabolism and skin / mucous membrane maintenance (Tier 1 nutritional).
Weaker / Emerging
Claims that niacin enhances Active Botanical effects (Tier 3–4, community-theory only).
Claim Caution
Moderate
Reason
Niacin nutrition is well-established. The protocol-pairing rationale is community theory, not research, and should be framed accordingly.
Science Hub

For the customer who wants the full picture.

Read the Deeper Technical Version

Niacin (vitamin B3) is an essential water-soluble vitamin with two principal supplement forms: nicotinic acid (the flush form) and nicotinamide / niacinamide (the non-flush form). Both forms convert to NAD+ in the body, supporting central cellular energy metabolism. Only the flush form activates GPR109A-mediated skin vasodilation, the visible flush experience.

Within microdosing community protocols, particularly the Stamets cycling framework, low-dose flush-form niacin (25–50mg) is paired with Active Botanical and Lion's Mane on dose days. The proposed rationale — peripheral circulation, possible distribution support — is community theory rather than research-backed pharmacology.

MYKO references niacin on Active Botanical product label directions as optional pairing, not as an enhancer. We do not claim that niacin increases Active Botanical effects, and we do not claim that it is required for the formula to work. Customers who prefer to skip niacin can do so without compromising the MYKO product.

Confirm final on-label wording across all five label SVGs — see the Pre-Read flags section.

References

Direct human-outcome citations specific to this ingredient are limited or not yet referenced inline on this page. See the MYKO Ingredient Hub for the full evidence base, and the Science page for the broader formulation literature.

Safety Notes

What to know before using.

  • Flush-form niacin causes transient skin flushing — uncomfortable but generally not dangerous at 25–50mg.
  • High-dose niacin (1g+ daily) can cause liver stress; do not exceed 100mg/day without practitioner supervision in a protocol context.
  • Use caution with diabetes — niacin can affect blood glucose.
  • Use caution with gout — niacin can affect uric acid.
  • Use caution with liver disease — niacin metabolism is hepatic.
  • Use caution with statins — increased risk of muscle issues.
  • Use caution with blood-pressure medications — niacin contributes to vasodilation.
  • Avoid in pregnancy and breastfeeding above standard nutritional doses.
Research Notes

What's supported, what's emerging.

What is reasonably supported: B3's nutritional role in energy metabolism; therapeutic-dose lipid management (clinical context, not relevant to MYKO).

What is still emerging: the specific role of low-dose niacin within Active Botanical protocols.

What should not be claimed strongly: "enhances Active Botanical effects," "increases neuroplasticity," "required for microdosing benefits."

Where more human research is needed: properly designed studies of low-dose niacin pairing with Active Botanical formulas.

Where It Leads

Meet the formulas built on it.

Every MYKO ingredient earns its place in a formula. See the systems it powers — or find the one built for you.

These statements have not been evaluated by the U.S. Food and Drug Administration. MYKO products are not intended to diagnose, treat, cure, or prevent any disease.

Information on this site is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. Consult a qualified healthcare practitioner before beginning any new supplement, particularly if you are pregnant, breastfeeding, taking medication, or managing a medical condition.